Related MeSH Hierarchy (10)
Diseases [C] » Otorhinolaryngologic Diseases [C09] » Ear Diseases » Hearing Disorders » Hearing Loss » Deafness » Deaf-Blind Disorders » Usher Syndromes
Diseases [C] » Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16] » Congenital Abnormalities » Abnormalities, Multiple » Deaf-Blind Disorders » Usher Syndromes
Diseases [C] » Pathological Conditions, Signs and Symptoms [C23] » Signs and Symptoms » Neurologic Manifestations » Sensation Disorders » Hearing Disorders » Hearing Loss » Hearing Loss, Sensorineural » Usher Syndromes
Diseases [C] » Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16] » Genetic Diseases, Inborn » Eye Diseases, Hereditary » Retinitis Pigmentosa » Usher Syndromes
Diseases [C] » Otorhinolaryngologic Diseases [C09] » Ear Diseases » Hearing Disorders » Hearing Loss » Hearing Loss, Sensorineural » Usher Syndromes
Diseases [C] » Nervous System Diseases [C10] » Neurologic Manifestations » Sensation Disorders » Hearing Disorders » Hearing Loss » Deafness » Deaf-Blind Disorders » Usher Syndromes
Diseases [C] » Nervous System Diseases [C10] » Neurologic Manifestations » Sensation Disorders » Hearing Disorders » Hearing Loss » Hearing Loss, Sensorineural » Usher Syndromes
Diseases [C] » Nervous System Diseases [C10] » Neurologic Manifestations » Sensation Disorders » Vision Disorders » Blindness » Deaf-Blind Disorders » Usher Syndromes
Diseases [C] » Eye Diseases [C11] » Retinal Diseases » Retinal Degeneration » Retinal Dystrophies » Retinitis Pigmentosa » Usher Syndromes
Diseases [C] » Eye Diseases [C11] » Vision Disorders » Blindness » Deaf-Blind Disorders » Usher Syndromes
Description
Autosomal recessive hereditary disorders characterized by congenital SENSORINEURAL HEARING LOSS and RETINITIS PIGMENTOSA. Genetically and symptomatically heterogeneous, clinical classes include type I, type II, and type III. Their severity, age of onset of retinitis pigmentosa and the degree of vestibular dysfunction are variable. MeSH
Hierarchy View
Phase 2 Indicated Drugs (1)
Organization Involved with Phase 2 Indications (9)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
